Marie‐Christine Pérault‐Pochat

Author

Centre Hospitalier Universitaire de Poitiers

Also Known As

Marie-Christine Perault-Pochat, Marie-Christine Pérault-Pochat, Marie‐Christine Perault‐Pochat, Marie‐Christine Pérault‐Pochat, PERAULT-POCHAT, M. C., Stéphanie Pain

Publications

569

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Poitiers Inserm Université de Poitiers Centre Hospitalier Universitaire de Bordeaux Bordeaux Population Health

About

Marie‐Christine Pérault‐Pochat is an author at Centre Hospitalier Universitaire de Poitiers specializing in pharmacotherapy, medicine, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	206
2	Public Health	2	2	144
3	Emergency Medicine	1	1	132
4	Epidemiology	1	1	132
5	Health Policy	1	1	12

Marie‐Christine Pérault‐Pochat

Publications

484

Citations

H-Index

Page 1

	Year	Citations
Incidence of hospital admissions due to adverse drug reactions in <scp>F</scp>rance: the <scp>EMIR</scp> study Anne Bénard‐Laribière, Ghada Miremont‐Salamé, Marie‐Christine Pérault‐Pochat, Fundamental and Clinical Pharmacology Hospital AdmissionsPharmacotherapyAdverse Drug ReactionPreventable AdrsHospital Medicine	2014	132
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer Marion Allouchery, Thomas Lombard, M. Martin, Journal for ImmunoTherapy of Cancer	2020	117
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France Chantal Barin‐Le Guellec, Claire Lafay‐Chebassier, Isabelle Ingrand, European Journal of Cancer MedicineMetronomic TherapyPharmacologyChemotherapy RegimensReal-life Evaluation	2019	62
Drugs and dilated cardiomyopathies: a case/noncase study in the French PharmacoVigilance Database Guillaume Montastruc, Sylvie Favrelière, Agnès Sommet, British Journal of Clinical Pharmacology	2009	48
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study Marie‐Laure Laroche, Marie‐Christine Pérault‐Pochat, Isabelle Ingrand, Pharmacoepidemiology and Drug Safety	2013	45
Adverse events of recreational cannabis use reported to the French addictovigilance network (2012–2017) Émilie Bouquet, Stéphanie Pain, Céline Eiden, British Journal of Clinical Pharmacology	2021	20
Beta‐lactam‐induced severe neutropaenia: a descriptive study Thierry Vial, Henry Bailly, Marie‐Christine Pérault‐Pochat, Fundamental and Clinical Pharmacology	2018	19
Adverse events reported for Mirena levonorgestrel‐releasing intrauterine device in France and impact of media coverage Claire Langlade, Amandine Gouverneur, Pauline Bosco‐Lévy, British Journal of Clinical Pharmacology	2019	19
The French pharmacovigilance surveys: A French distinctiveness, a real input Malak Abou Taam, Baptiste Jacquot, Claire Ferard, Therapies Drug SafetySubstance AbuseHealth PolicyFrench Pharmacovigilance SurveysMedicine	2020	12
Patterns of ketamine use among people with substance use disorder in France: Multisource analysis of the data from the French Addictovigilance Network Pauline Gandolfo, Thomas Soeiro, Élisabeth Jouve, Fundamental and Clinical Pharmacology	2024	10

Page 1